FDA approves new treatment for adults with migraine

FDA approves Ubrelvy (ubrogepant) tablets for the acute treatment of migraine with or without aura in adults.

Source: FDA Center for Drug Evaluation and Research - What's New - December 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news